Showing results (461-470 of 711) with videos related to
Sort By:
Pageof 72
European Journal of Pharmacology|August 2, 2005
Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel kappa-opioid receptor agonist nalfurafine hydrochlorideHideo Umeuchi, Yumi Kawashima, Christopher A Aoki, et al.Journal of Autoimmunity|April 26, 2005
Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosisKerstien A Padgett, Carlo Selmi, Thomas P Kenny, et al.Scientific Reports|November 12, 2017
A Mouse Model of Autoimmune Cholangitis via Syngeneic Bile Duct Protein ImmunizationWen-Tao Ma, Qing-Zhi Liu, Jing-Bo Yang, et al.Journal of Autoimmunity|October 1, 2019
Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseasesChuan Huang, Hao-Xian Zhu, Yuan Yao, et al.Journal of Hepatology|October 22, 2003
Cytochrome P450 2A6: a new hepatic autoantigen in patients with chronic hepatitis C virus infectionGeorgios N Dalekos, Petra Obermayer-Straub, Moritz Bartels, et al.Hepatology (Baltimore, Md.)|November 13, 2009
CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosisShinji Shimoda, Kenichi Harada, Hiroaki Niiro, et al.Annals of the New York Academy of Sciences|September 7, 2007
The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosisAtsushi Tanaka, Saeko Nezu, Satoko Uegaki, et al.Developmental Immunology|October 2, 2002
Increased frequency of pre-pro B cells in the bone marrow of New Zealand Black (NZB) mice: implications for a developmental block in B cell differentiationZhe-Xiong Lian, Hiroto Kita, Tomoyuki Okada, et al.Hepatology (Baltimore, Md.)|October 27, 2005
Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patientsM Eric Gershwin, Carlo Selmi, Howard J Worman, et al.Cellular & Molecular Immunology|August 30, 2022
Treatment with a JAK1/2 inhibitor ameliorates murine autoimmune cholangitis induced by IFN overexpressionTihong Shao, Patrick S C Leung, Weici Zhang, et al.Pageof 72